Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Kim

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Experimental Medicine|June 11, 2024
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in miceKelsey A Toth, Erica G Schmitt, Ana Kolicheski, et al.
The Journal of Allergy and Clinical Immunology|July 15, 2023
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitisEmma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, et al.
Journal of the American Academy of Dermatology|March 6, 2020
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOSJonathan I Silverberg, Gil Yosipovitch, Eric L Simpson, et al.
Immunity|July 1, 2018
TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle CellsJialie Luo, Aihua Qian, Landon K Oetjen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Archives of Dermatological Research|October 22, 2016
CD164 identifies CD4<sup>+</sup> T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214Bernice M Benoit, Neha Jariwala, Geraldine O'Connor, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoLea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
RAG suppresses group 2 innate lymphoid cellsAaron M Ver Heul, Madison Mack, Lydia Zamidar, et al.
Elife|May 6, 2025
RAG suppresses group 2 innate lymphoid cellsAaron M Ver Heul, Madison Mack, Lydia Zamidar, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription FactorsHisato Iriki, Ruiqi Hu, Xu Li, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|June 11, 2024
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in miceKelsey A Toth, Erica G Schmitt, Ana Kolicheski, et al.
The Journal of Allergy and Clinical Immunology|July 15, 2023
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitisEmma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, et al.
Journal of the American Academy of Dermatology|March 6, 2020
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOSJonathan I Silverberg, Gil Yosipovitch, Eric L Simpson, et al.
Immunity|July 1, 2018
TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle CellsJialie Luo, Aihua Qian, Landon K Oetjen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Archives of Dermatological Research|October 22, 2016
CD164 identifies CD4<sup>+</sup> T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214Bernice M Benoit, Neha Jariwala, Geraldine O'Connor, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoLea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
RAG suppresses group 2 innate lymphoid cellsAaron M Ver Heul, Madison Mack, Lydia Zamidar, et al.
Elife|May 6, 2025
RAG suppresses group 2 innate lymphoid cellsAaron M Ver Heul, Madison Mack, Lydia Zamidar, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription FactorsHisato Iriki, Ruiqi Hu, Xu Li, et al.
Pageof 18